These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 16245248

  • 1. Mycophenolate mofetil in the treatment of steroid-resistant primary focal segmental glomerulosclerosis.
    Tang S, Ho YW, Leung CY, Lai KN.
    J Nephrol; 2005; 18(4):429-32. PubMed ID: 16245248
    [Abstract] [Full Text] [Related]

  • 2. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J, Ehrich JH, Querfeld U.
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [Abstract] [Full Text] [Related]

  • 3. Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study.
    Soliman AR, Maamoun H, Soliman H, Ahmed RM.
    Rom J Intern Med; 2021 Jun 01; 59(2):127-133. PubMed ID: 33565308
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis.
    Cattran DC, Wang MM, Appel G, Matalon A, Briggs W.
    Clin Nephrol; 2004 Dec 01; 62(6):405-11. PubMed ID: 15630898
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of combined cyclosporin A and mycophenolate mofetil therapy in patients with cyclosporin-resistant focal segmental glomerulosclerosis.
    Segarra Medrano A, Vila Presas J, Pou Clavé L, Majó Masferrer J, Camps Doménech J.
    Nefrologia; 2011 Dec 01; 31(3):286-91. PubMed ID: 21468162
    [Abstract] [Full Text] [Related]

  • 6. Other immunosuppressive agents for focal segmental glomerulosclerosis.
    Ponticelli C, Passerini P.
    Semin Nephrol; 2003 Mar 01; 23(2):242-8. PubMed ID: 12704585
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of Different Immunosuppressive Regimen in Adult Biopsy Proven Idiopathic Focal Segmental Glomerulosclerosis: A Retrospective Analysis at a Single Center.
    Qureshi R, Nasir K, Imtiaz S, Dhrolia MF, Ahmad A, Salman B.
    Saudi J Kidney Dis Transpl; 2022 Mar 01; 33(1):111-121. PubMed ID: 36647985
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.
    Senthil Nayagam L, Ganguli A, Rathi M, Kohli HS, Gupta KL, Joshi K, Sakhuja V, Jha V.
    Nephrol Dial Transplant; 2008 Jun 01; 23(6):1926-30. PubMed ID: 17989103
    [Abstract] [Full Text] [Related]

  • 9. Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.
    Troost JP, Trachtman H, Spino C, Kaskel FJ, Friedman A, Moxey-Mims MM, Fine RN, Gassman JJ, Kopp JB, Walsh L, Wang R, Gipson DS.
    Am J Kidney Dis; 2021 Feb 01; 77(2):216-225. PubMed ID: 32791086
    [Abstract] [Full Text] [Related]

  • 10. The treatment of idiopathic focal segmental glomerulosclerosis in adults.
    Hogan J, Radhakrishnan J.
    Adv Chronic Kidney Dis; 2014 Sep 01; 21(5):434-41. PubMed ID: 25168833
    [Abstract] [Full Text] [Related]

  • 11. Low-dose methylprednisolone pulse therapy in Chinese children with steroid resistant focal segmental glomerulosclerosis.
    Chang JW, Yang LY, Wang HH.
    Pediatr Int; 2007 Jun 01; 49(3):349-54. PubMed ID: 17532834
    [Abstract] [Full Text] [Related]

  • 12. Plasmapheresis-induced remission in otherwise therapy-resistant FSGS.
    Vécsei AK, Müller T, Schratzberger EC, Kircher K, Regele H, Arbeiter K, Schroth B, Aufricht C.
    Pediatr Nephrol; 2001 Nov 01; 16(11):898-900. PubMed ID: 11685597
    [Abstract] [Full Text] [Related]

  • 13. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
    El-Reshaid K, El-Reshaid W, Madda J.
    Ren Fail; 2005 Nov 01; 27(5):523-30. PubMed ID: 16152989
    [Abstract] [Full Text] [Related]

  • 14. A prospective study of collapsing focal segmental glomerulosclerosis.
    Raja R, Nada R, Yadav AK, Kumar A, Goyal A, Kumar V, Rathi M, Kohli HS, Gupta KL, Sakhuja V, Jha V.
    Ren Fail; 2016 Jul 01; 38(6):894-8. PubMed ID: 27266801
    [Abstract] [Full Text] [Related]

  • 15. [Mycophenolate mofetil in the treatment of primary nephrotic syndrome].
    Zhao M, Chen X, Chen Y, Liu Z, Liu Y, Lu F, Zhang Y, Wang H.
    Zhonghua Yi Xue Za Zhi; 2001 May 10; 81(9):528-31. PubMed ID: 11809115
    [Abstract] [Full Text] [Related]

  • 16. Focal segmental glomerulosclerosis in children.
    Jellouli M, Abidi K, Askri M, Ferjani M, Naija O, Hammi Y, Goucha R, Gargah T.
    Tunis Med; 2016 May 10; 94(5):356-359. PubMed ID: 27801486
    [Abstract] [Full Text] [Related]

  • 17. Raised serum creatinine at presentation does not adversely affect steroid response in primary focal segmental glomerulosclerosis in adults.
    Jafry N, Ahmed E, Mubarak M, Kazi J, Akhter F.
    Nephrol Dial Transplant; 2012 Mar 10; 27(3):1101-6. PubMed ID: 21804085
    [Abstract] [Full Text] [Related]

  • 18. Current and emerging treatments for idiopathic focal and segmental glomerulosclerosis in adults.
    Ponticelli C, Graziani G.
    Expert Rev Clin Immunol; 2013 Mar 10; 9(3):251-61. PubMed ID: 23445199
    [Abstract] [Full Text] [Related]

  • 19. [Steroid-resistant focal segmental glomerulosclerosis treated with cascade plasmafiltration and rituximab].
    Tatangelo P, Londrino F, Di Vasta G, Guido G, Centi A, Dominijanni S, Bernabei E, Caramiello MS, Di Franco D, Palumbo R.
    G Ital Nefrol; 2018 May 10; 35(3):. PubMed ID: 29786187
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome.
    Day CJ, Cockwell P, Lipkin GW, Savage CO, Howie AJ, Adu D.
    Nephrol Dial Transplant; 2002 Nov 10; 17(11):2011-3. PubMed ID: 12401863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.